Nyrada Inc
NYR
Company Profile
Business description
Nyrada Inc is a preclinical-stage, drug discovery, and development company, specializing in novel small-molecule drugs to treat cardiovascular and neurological diseases. The company's two programs center on cholesterol-lowering and brain injury, each targeting market sectors of notable size and unmet clinical needs. The programs are focused on developing an oral, small molecule cholesterol-lowering drug, and a drug to treat secondary brain damage following a stroke or traumatic brain injury.
Contact
828 Pacific Highway
Suite 2, Level 3
GordonNSW2072
AUST: +61 294983390
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2025
Employees
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,624.90 | 6.60 | -0.08% |
CAC 40 | 7,788.10 | 38.69 | -0.49% |
DAX 40 | 24,038.19 | 188.30 | -0.78% |
Dow JONES (US) | 42,098.70 | 244.95 | -0.58% |
FTSE 100 | 8,726.01 | 52.04 | -0.59% |
HKSE | 23,258.31 | 123.68 | -0.53% |
NASDAQ | 19,100.94 | 98.22 | -0.51% |
Nikkei 225 | 37,722.40 | 1.71 | -0.00% |
NZX 50 Index | 12,362.26 | 220.07 | -1.75% |
S&P 500 | 5,888.55 | 32.99 | -0.56% |
S&P/ASX 200 | 8,396.90 | 10.70 | -0.13% |
SSE Composite Index | 3,339.93 | 0.76 | -0.02% |